Mortality rates and epidemiological changes in critically ill Coronavirus Disease 2019 patients after a vaccination program in Brazil
Authors:
- Donato da Silva Braz JuniorDJDonato da Silva Braz Junior
- Guilherme Jorge CostaGCGuilherme Jorge Costa
- Nathália Alves de Barros E LyraNLNathália Alves de Barros E Lyra
- Mirela Muniz Arantes VianaMVMirela Muniz Arantes Viana
- Vinícius Santos BorbaVBVinícius Santos Borba
- Luiz Claudio Santos ThulerLTLuiz Claudio Santos Thuler
- Eduardo Jorge da Fonseca LimaELEduardo Jorge da Fonseca Lima
- Maria Júlia Gonçalves de MelloMMMaria Júlia Gonçalves de Mello
- 23 September 2022
- journal article
- letter
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 48 (5) , e20220268
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Therapeutics and COVID-19: living guideline2022
- First and second COVID-19 waves in Brazil: A cross-sectional study of patients’ characteristics related to hospitalization and in-hospital mortalityThe Lancet Regional Health - Americas, 2021
- Letter from BrazilRespirology, 2021
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyBMJ, 2021
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance dataThe Lancet, 2021
- Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide dataThe Lancet Respiratory Medicine, 2021
- Dexamethasone in Hospitalized Patients with Covid-19New England Journal of Medicine, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2The Lancet Infectious Diseases, 2021